Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,671 total articles

VEON 2025 Integrated Annual Report: Record Digital Growth, Sovereign AI and Kyivstar Listing Define a Transformative Year

VEON 2025 Integrated Annual Report: Record Digital Growth, Sovereign AI and Kyivstar Listing Define a Transformative Year

VEON Ltd. reported strong financial and digital performance in 2025, with revenues up nearly 10% and digital service users surpassing connectivity customers for the first time. The company expanded its AI capabilities, strengthened ESG policies, increased renewable energy use, and saw Kyivstar become the first Ukrainian company listed on Nasdaq. VE…

Teck Reports Unaudited First Quarter Results for 2026

Teck Reports Unaudited First Quarter Results for 2026

Teck Resources Limited released its unaudited Q1 2026 results, posting significant earnings growth driven by record copper sales and higher commodity prices. The company achieved adjusted EBITDA of CAD 2.1 billion, a 125% increase year-over-year, with strong operational performance at Quebrada Blanca and continued progress toward the merger with An…

STMicroelectronics Reports Q1 2026 Financial Results

STMicroelectronics Reports Q1 2026 Financial Results

STMicroelectronics announced its Q1 2026 financial results, with net revenues increasing 23% year-over-year to $3.10 billion and gross margin at 33.8%. Despite a sequential revenue decline of 7%, the company exceeded its guidance midpoint, with solid demand in personal electronics and CECP. The recent acquisition of NXP's MEMS sensor business contr…

Marten Transport Announces First Quarter Results

Marten Transport Announces First Quarter Results

Marten Transport, Ltd. (Nasdaq: MRTN) reported a decline in net income to $1.4 million for Q1 2026, down from $4.3 million the previous year, driven by decreased operating revenue and increased operating expenses amid prolonged adverse freight market conditions, severe winter storms, and a spike in diesel prices. Despite these headwinds, the compan…

Elevra Lithium Quarterly Activities Report

Elevra Lithium Quarterly Activities Report

Elevra Lithium Limited delivered improved operational results at its North American Lithium mine, achieving record quarterly revenue of $81 million amidst strong lithium market conditions. The company advanced expansion plans and key projects including the ratification of the Ewoyaa Mining Lease in Ghana, engaged in strategic partnerships for downs…

SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, APRIL 23, AT 9:30 AM CENTRAL TIME

SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, APRIL 23, AT 9:30 AM CENTRAL TIME

Southern Missouri Bancorp, Inc. announced preliminary Q3 fiscal 2026 net income of $17.8 million, up 13.3% from the prior year, driven by higher net interest income and noninterest income despite increased provisions for credit losses. Earnings per share rose 15.1% to $1.60. The company declared a quarterly dividend of $0.25 per share, marking its …

nCino Announces Nick Edwards as Managing Director for APAC

nCino Announces Nick Edwards as Managing Director for APAC

nCino, a US-based provider of a platform for agentic banking, has appointed Nick Edwards as Managing Director for the Asia-Pacific region to accelerate growth and deepen customer relationships. Edwards brings nearly two decades of regional financial services experience and leadership from FNZ Group and Temenos. The company aims to leverage his expe…

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Regeneron Pharmaceuticals and Sanofi announced FDA approval of Dupixent (dupilumab) for treating children aged 2 to 11 years with chronic spontaneous urticaria (CSU) who remain symptomatic despite antihistamine treatment. This approval expands Dupixent's indication from adults and adolescents to younger children, based on data from the LIBERTY-CUPI…

Oak Valley Bancorp Reports 1st Quarter Results

Oak Valley Bancorp Reports 1st Quarter Results

Oak Valley Bancorp announced its unaudited Q1 2026 financial results, showing net income of $5.3 million and EPS of $0.64, relatively stable compared to the previous year but down from the prior quarter due to higher operating expenses and lower net interest income. The bank maintained a strong balance sheet, grew loan portfolios, and experienced s…